DVS-223 SR
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DVS-223 SR, covering 2007-01-11 to 2007-01-11. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause [Phase 3]